All In Biotech

Drug Trial Radar · NCT04536051

A Study of a Candidate COVID-19 Vaccine (COV003)

A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine

Last checked: Nov 19, 2026Latest source record: Nov 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 10,300 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

10,300

Planned (sponsor's estimate)

Start

Jun 2, 2020

Primary completion

Sep 2021

Study completion Sep 2021

Sponsor

Lead sponsor
University of OxfordAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Sequential
Masking
Single (participant)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine.

Conditions

  • Coronavirus

Interventions

  • ChAdOx1 nCoV-19 single dose + paracetamolBiological

    Single dose of ChAdOx1nCOV19 vaccine, 5x10\^10 vp + paracetamol

  • MenACWY single dose + paracetamolBiological

    Single dose of MenACWY + paracetamol

  • ChAdOx1 nCoV-19 two dose + paracetamolBiological

    Two dose of ChAdOx1 nCoV-19 vaccine, 5x10\^10vp (prime) and 0.5mL boost (3.5 - 6.5 × 10\^10 vp), 4-12 weeks apart + paracetamol

  • MenACWY prime & saline placebo boost + paracetamolBiological

    MenACWY prime, and Saline Placebo boost (0.5mL) + paracetamol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the efficacy of ChAdOx1 nCoV-19 vaccine against COVID-19 disease confirmed with PCRTime frame: 12 months post final vaccination

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Instituto D'Or de Pesquisa e Ensino - I'Dor

    Rio de Janeiro, Brazil · Recruiting

  • CRIE, Universidade Federal de São Paulo

    São Paulo, Brazil · Recruiting

  • Instituto D'Or de Pesquisa e Ensino - I'Dor

    Salvador, Estado de Bahia, Brazil · Recruiting

  • Centro de Pesquisas Clinicas de Natal (CPCLIN)

    Natal, Rio Grande do Norte, Brazil · Recruiting

  • Hospital das Clinicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Universidade Federal de Santa Maria (UFSM)

    Santa Maria, Rio Grande do Sul, Brazil · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.